
22nd Century Group: News
October 2026: 22nd Century Group Reports 161% Same-Store Sales Growth for Pinnacle VLN and Pinnacle Pure in Q3 2026 22nd Century Group reported that combined

October 2026: 22nd Century Group Reports 161% Same-Store Sales Growth for Pinnacle VLN and Pinnacle Pure in Q3 2026 22nd Century Group reported that combined

October 2026: Philip Morris International Prepares for Q3 2026 Earnings as Shares Hold Above $200 Record Highs Philip Morris International (PMI) is scheduled to report

October 2026: GQG Partners Sells 2.91% Stake in ITC as Stock Faces Sustained Downward Pressure US-based asset management firm GQG Partners, founded by investor Rajiv

Imperial Brands has confirmed in its pre-close trading update for FY26 (ended September 30, 2026) that it remains on track to deliver full-year guidance across

October 2026: Emtech Files Regulatory Complaint Against KT&G Over Alleged Forced Patent Transfers and Retaliatory Trade Cuts South Korean e-cigarette device manufacturer Emtech has reported

Three key trends force tobacco companies to continuously re-assess and optimize their manufacturing footprint: (1) Cost savings: Transferring labor intensive operations to lower-cost countries within

Background Scandinavian Tobacco Group (STG) became a pure-play cigar & pipe tobacco manufacturer, following the acquisition of its cigarette & snus business (“House of Prince”) by BAT in 2008.

September 2026: Ispire Technology Joint Venture Unveils IKE 2.0 to Drive Continuous Compliance Beyond the Point of Sale IKE Tech, a Joint Venture between Ispire

September 2026: BAT Announces Horizon 2030 Strategy and Reaffirms 2026 Targets Ahead of its 2026 Capital Markets Day in Winston-Salem, North Carolina – the historic

Three key trends force tobacco companies to continuously re-assess and optimize their manufacturing footprint: (1) Cost savings: Transferring labor intensive operations to lower-cost countries within

September 2026: Turning Point Brands Appoints David E. Glazek as CEO as Graham Purdy Steps Down Turning Point Brands, Inc. (NYSE: TPB) has announced that

September 2026: Charlie’s Holdings Shifts Focus to Age-Gated Flavored Vapes Amid Improving US Regulatory Landscape Charlie’s Holdings announced a major strategic pivot toward launching America’s

September 2026: Altria Breaks Ground on $250 Million Manufacturing Expansion in Hopkinsville, Kentucky Altria Group has officially broken ground on a $250 million expansion of

Focus2030 Advances with Category Stabilization, Portfolio Rationalization, and Reaffirmed Guidance Scandinavian Tobacco Group (STG) published its financial results for the second quarter of 2026, demonstrating

August 2026: China Tobacco International (HK) Reports H1 2026 Revenue Decline Amid Import Headwinds as Export Growth Sustains Earnings China Tobacco International (HK) Company Limited

August 2026: Haypp Group Secures SEK 400 Million Credit Facility with Danske Bank Haypp Group has entered into a SEK 400 million revolving credit facility

AIR H1 2026 Results: Resilient Core Growth Amid Geopolitical Disruption AIR Global (NASDAQ: AIIR), the global leader in Flavored Shisha Molasses (FSM) and an innovator

August 2026: Heated Tobacco Hyper-Growth and European ODM Expansion Power Record Smoore H1 2026 Revenue Smoore delivered strong operational performance during H1 2026, setting a

August 14, 2026: RLX Q2 2026 Results RLX Technology reported a resilient second quarter for 2026, headlined by 14.8% YoY net revenue growth to RMB

Q2 2026: Record Net Sales & Peak Gross Margin During the second quarter of 2026, Haypp Group achieved its highest organic volume and sales growth

August 2026: S&P Global Ratings Re-affirms KT&G’s Credit Rating at “A-” with Outlook Stable S&P Global Ratings has reaffirmed its A- long-term issuer credit rating

August 2026: Imperial Brands to Cut Thousands of Jobs in Major US and European Restructuring Imperial Brands is preparing to eliminate thousands of jobs across

August 2026: S&P Global Assigns ‘BBB-‘ Rating to BAT’s Perpetual Subordinated Hybrid Instruments S&P Global Ratings has assigned a ‘BBB-‘ long-term issue rating to British

Executive Summary KT&G Corporation delivered a profit-led Q2 2026 beat, characterized by double-digit operating profit expansion that outpaced top-line growth across all core operating divisions.

Executive Summary Turning Point Brands (TPB) reported its financial results for the second quarter ended June 30, 2026, demonstrating continued top-line expansion fueled by hyper-growth

Executive Summary: Earnings Compression Driven by Cigarette Tax Adjustments ITC Limited’s Q1 FY2026/27 (Q1 FY27) financial results for the quarter ended June 30, 2026, present

July 2026: AIR Strengthens Partnership with Greentank Innovations Through $20 Million Equity Investment AIR Global has announced a US$20 million strategic equity investment in Canadian

Ahead of the Q2 2026 Earnings release Date: July 30, 2026 (Thursday), Before Market Open Consensus Estimates: $5.35 billion Revenue (+1.1% yoy); $1.50 EPS (+4.2% yoy) Guidance: Altria’s

Ahead of the Q2 2026 Earnings release Date: July 30, 2026 (Thursday), After Market Close Consensus Estimates: ¥986.2 billion Revenue (+8.7% yoy); ¥97.6 EPS (+6.6% yoy) Guidance: JT’s

Ahead of H1 2026 Earnings Release Release date: July 30, 2026 (before the opening bell) Revenue: £12.19 billion (+1.0% reported, +3.0% at constant currency) Adj.

July 2026:Tax Hike Weighs on Godfrey Phillips as Q1 Profit Drops 44% Godfrey Phillips India Ltd, the manufacturer of Marlboro and Four Square in India,

Three key trends force tobacco companies to continuously re-assess and optimize their manufacturing footprint: (1) Cost savings: Transferring labor intensive operations to lower-cost countries within

July 2026: JT Expands Processed Food Operations and Business Development Pipeline Japan Tobacco (JT) is expanding its non-tobacco capabilities, positioning its processed food segment as

Ahead of the Q2 2026 Earnings release Date: July 22, 2026 (Wednesday), before the bell Consensus: $10.6 billion revenue (+4.5% year-on-year); $2.03 EPS (+6.3% year-on-year) PMI FY26

July 2026: Delaware Judge Allows Second Lawsuit Challenging JUUL Rescue Deal to Proceed JUUL Labs will face a second shareholder lawsuit challenging the rescue financing

Ahead of the H1 2026 Trading Update release Date: June 2, 2026 (Tuesday), before the bell FY26 Consensus: At constant currency, 3.4% Revenue, 4.3% Adjusted profit from

KT&G: Global Expansion and Portfolio Diversification Drive Structural Revenue Shifts KT&G’s operational model relies on two primary revenue pillars: the traditional combustible cigarette brand ‘ESSE’

May 2026: Closing the Global Peer Discount via Operational Acceleration and Gold-Standard Capital Returns KT&G is undergoing a profound qualitative transformation, successfully transitioning from a

May 2026: Altria to Consolidate Smokeless and Nicotine Pouch Manufacturing in Kentucky Altria Group subsidiary U.S. Smokeless Tobacco Company (USSTC) has announced plans to modernize

ITC Limited has demonstrated a resilient financial performance for the fourth quarter ended March 31, 2026 (Q4 FY26), and the full fiscal year (FY26). This

Focus2030 Execution Begins Amid Online Competition and FX Headwinds Scandinavian Tobacco Group (STG) has released its financial results for the first quarter of 2026, marking

May 2026: Godfrey Phillips India Enters 3-Year Distribution Agreement for NRT Products in Strategic Move Into Smokeless Category Godfrey Phillips India has entered a three-year

PouchPoint.com: Convenience & Reliability in the Fast‑Changing U.S. Nicotine Pouch Market The nicotine pouch category in the United States has grown from a niche curiosity

Ahead of the H1 2026 Earnings release Date: May 12, 2026 (Tuesday), before the bell Guidance – H1 2026: Low single-digit growth in tobacco & NGP net

Japan Tobacco reported a strong start to FY2026, with broad-based growth across the tobacco business, continued pricing power in combustibles, accelerating reduced-risk product (RRP) momentum,

TPB Q1 2026 Results: Modern Oral Drives Growth as Guidance Raised Turning Point Brands (TPB) reported strong top-line growth in Q1 2026, primarily driven by

KT&G posted strong first quarter results, with consolidated revenue rising 14.3% YoY to ₩1.70 trillion and operating profit increasing 27.6% YoY to ₩364.5 billion. Net

Haypp Group Q1 2026: Strong Nicotine Pouch Growth Drives Record Sales as Investments Pressure Margins Haypp Group reported a strong start to 2026, with Q1

Ahead of the Q1 2026 Earnings release Date: April 30, 2026 (Thursday), Before Market Open Consensus Estimates: $4.58 billion Revenue (+1.3% yoy); $1.246 EPS (+1.3% yoy) Guidance: Altria’s

April 2026: S&P Downgrades Japan Tobacco to “A” on Geopolitical Risk Exposure, Maintains Stable Outlook S&P Global has lowered its long-term issuer credit rating on

Ahead of the Q1 2026 Earnings release Date: April 22, 2026 (Wednesday), before the bell Consensus: $9.88 billion revenue (+6.2% year-on-year); $1.83 EPS (+8.3% year-on-year) PMI FY26

April 2026: British American Tobacco Affiliate Holds 29.9% Stake in Organigram, With Path to 49% Organigram reported that its strategic investor, BT DE Investments, an

Headline: “FY26 guidance reiterated, but quality of the print looks weak” Imperial Brands: H1 2026 Trading Update – Key Points – Guidance reaffirmed: FY26 outlook

April 2026: Fitch affirms Turning Point Brands’ IDR at “B+”. Outlook Stable Fitch Ratings has affirmed Turning Point Brands’ (TPB) Long-Term Issuer Default Rating (IDR)

While dipping tobacco and snus are widely available throughout the US, it’s rare for stores to sell a comprehensive range of both products. Snus.us has

Three key trends force tobacco companies to continuously re-assess and optimize their manufacturing footprint: (1) Cost savings: Transferring labor intensive operations to lower-cost countries within

March 2026: Fitch Affirms Philip Morris International at “A”. Outlook Stable Fitch Ratings has affirmed Philip Morris International (PMI) Long-Term Issuer Default Rating (IDR) and

March 2026: ITC Faces Earnings Uncertainty as Tax Hikes and Margin Pressures Weigh on Outlook ITC Limited shares have declined to 30-month lows and are

Strong Revenue Rebound Masked by Margin Compression and Rising Costs Smoore International delivered a notable top-line recovery in FY2025, with revenue rising 20.8% year-on-year to

China Tobacco International Reports Solid FY2025 Growth as Leaf Trading Drives Performance China Tobacco International (HK) Company Limited reported solid financial results for fiscal year

Scandinavian Tobacco Group Reports Weaker 2025 Results Amid Market Headwinds and Strategic Transition Scandinavian Tobacco Group (STG) reported weaker financial results for Q4 2025 and

March 2026: Scandinavian Tobacco Group Reduces Annual Dividend to kr.4.50 Scandinavian Tobacco Group proposes an ordinary dividend of kr.4.50 per share for 2026, corresponding to

March 2026: Turning Point Brands Accelerates Modern Oral Expansion, Steps Up Investment in 2026 Turning Point Brands (TPB) reported strong fourth quarter and full-year 2025

February 2026: Fitch Upgrades Altria to BBB+ Fitch Ratings upgraded Altria’s Long-Term Issuer Default Rating (IDR) to “BBB+” from “BBB” and Short-Term IDR to “F1” from

– Net sales: up +15% to kr.1,052.2 million (+19% cc) in Q4 2025 and up 5% kr.3,848.9 million (+7% cc) in FY25. First-time above kr.1

Release date: February 12, 2026; before the LSE opening Consensus ahead of the release: +1.9% revenue and 2.0% operating profit growth in FY25; Acceleration in

As the tobacco-free market continues to expand, it has created a golden opportunity for e-commerce stores. Prilla.com, an online retailer that sells to the US

Consolidated Results FY25 Revenue up +13.4% to ¥3,467.7 billion (+13.9% at constant FX); Adjusted operating profit up +21.5% to ¥902.2 billion (+24.9% at constant FX)

Ahead of the Q4 2025 & FY25 Earnings release Release date: February 6, 2026 (before the opening bell) Revenue: $10.38 billion expected (+6.9% vs. $9.71

Q4 2025 & FY25 Results Revenue: ₩1.71Tn in Q4 (+10.1% year-on-year), ₩6.58Tn in FY25 (+11.4%) EBITDA: ₩325.8Bn in Q4 (+17.7%), ₩1.64Tn in FY25 (+14.1%) EBITDA

January 2026: Altria Advances Non-Nicotine Expansion Strategy As part of its 2028 Enterprise Goals, Altria plans to expand into non-nicotine categories, targeting broad commercial distribution

Key Business Metrics: Q3 2026 – New reporting structure: Standalone (core businesses) vs. Consolidated (including ITC Infotech India Limited, Surya Nepal Private Limited and ITC

Ahead of Q4 2025 Earnings release Release date: January 29, 2026 (before the opening bell) Revenue: $5.03 billion expected (-1.5% vs. $5.106Bn in Q4 2024)

Three key trends force tobacco companies to continuously re-assess and optimize their manufacturing footprint: (1) Cost savings: Transferring labor intensive operations to lower-cost countries within

Karelia Tobacco Company is Greece’s largest cigarette manufacturer & exporter and one of the largest independent tobacco companies in the world (i.e. not belonging to

December 2025: Fitch Affirms Imperial Brands’ “BBB” Credit Rating. Outlook Stable Fitch Ratings affirmed Imperial Brands’s long-term issuer default rating (IDR) and senior unsecured instrument

December 2025: Philip Morris International – KT&G Partership Agreement is revised KT&G announced that it revised the key contractual terms related to its 15-year long-term

Ahead of the FY25 Trading Update release Release date: December 9, 2025 (before the LSE opening bell) Consensus estimates: 2.1% revenue and 2.1% adj. operating

December 2025: Japan Tobacco completes the transfer of its pharmaceutical business to Shionogi Japan Tobacco (JT) completed the transfer of its pharmaceutical business to the

22nd Century Group is pioneering very low nicotine (VLN) cigarettes with the aim to give millions of smokers the choice to take control of their

Scandinavian Tobacco Group opened its 2025 Capital Markets Day by situating the event within a decade-long corporate journey that began with the company’s listing on

– Tobacco & NGP Net revenue up +4.1% on a constant FX basis to £8.32 billion (vs. +3% exp.) – Adjusted Operating profit up +4.6%

Background Scandinavian Tobacco Group (STG) is the world’s 15th largest publicly traded tobacco company by market cap. STG became a pure-play cigar & pipe tobacco manufacturer,

Q3 2025 Results “Double-digit revenue and operating profit growth, mainly driven by the international cigarette division”s Revenue: ₩1.83 trillion (+11.6% year-on-year) => record-high quarterly revenue,

November 5, 2025: Q3 2025 Results1 LFL (like-for-like) adjustment: excluding the impact of the ZYN shortage, discontinuation of tobacco sales and state closures in the

Key Business Metrics: Q2 2026 – New reporting structure: Standalone (core businesses) vs. Consolidated (including ITC Infotech India Limited, Surya Nepal Private Limited and ITC

Ahead of Q3 2025 Earnings release Release date: October 30, 2025 (before the opening bell) Revenue: $5.29 billion expected (-1% vs. $5.344Bn in Q3 2024)

Revenue: ¥947.2Bn (versus ¥901Bn expected) EPS: ¥109 (versus ¥92.9 expected) Starting from Q3 2025, the Pharmaceutical business is classified as discontinued operations Top-line & Bottom-line

Ahead of the Q3 2025 Earnings release Release date: October 21, 2025 (before the opening bell) Revenue: $10.64 billion expected (+7.4% vs. $9.91 billion in

October 2025: Q3 2025 Results1 Smoore’s quarterly revenue increased +27.2% year-on-year (+27.5% sequentially) to ¥4,196.8 million in Q3 2025 – setting a new record high

On track to deliver FY25 guidance. £1.45 billion share buyback in FY26, to completed no later than 28 October 2026 (+16% increase compared to £1.25

September 2025: Fitch affirmed Universal Corporation’s BBB- issuer rating. Outlook Negative Fitch Ratings affirmed all ratings for Universal Corporation, including the company’s Long-Term Issuer Default

August 22, 2025: Q2 2025 Results Net revenue: up +40.3% to ¥880.0 million (US$122.8 million), up +8.9% on sequential basis Gross margin: up +2.3pp to

August 2025: H1 2025 Results1 China Tobacco International (CTI) reported both revenue growth and improved profitability in H1 2025 despite margin pressure in certain segments.

Q2 2025 Results “Solid financial delivery, driven by the international cigarette division” Revenue: ₩1.55 trillion (+8.7% year-on-year) => record-high first half revenue, surpassing ₩3 trillion

Key Business Metrics: Q1 2026 – New reporting structure: Standalone (core businesses) vs. Consolidated (including ITC Infotech India Limited, Surya Nepal Private Limited and ITC

Top-line & Bottom-line Results – Tobacco Segment Only (Excluding Pharmaceuticals and Processed Food Segments. Tobacco Segment has a 90% weight in revenue and 100+% weight

Ahead of H1 2025 Earnings release Release date: July 31, 2025 (before the opening bell) Revenue: £12.0 billion (-2.7% reported, +1.2% at constant currency) EPS:

Ahead of Q2 2025 Earnings release Release date: July 30, 2025 (before the opening bell) Revenue: $5.19 billion expected (-1.7% vs. $5.28Bn in Q2 2024)

Ahead of the Q2 2025 Earnings release Release date: July 22, 2025 (before the opening bell) Revenue: $10.32 billion expected (+9% vs. $9.47 billion in

June 2025: Oettinger Davidoff reports CHF 541.7 million revenue in 2024 Following the record results in 2023 and 2022, Oettinger Davidoff’s sales turnover grew +0.9%

Ahead of the H1 2025 results (to be released on July 31, 2025), BAT provided an interim business update on June 3, 2025 (Tuesday). Key

Key Business Metrics: Q4 2025 & FY25 – Q4 2025: Gross Revenue up +9.2% and Operating Profit up +2.5% (ex-Paper, up +4.2%) – FY25: Gross

CEO Transition: Stefan Bomhard to be succeeded by Lukas Paravicini (CFO) as CEO on October 1, 2025. Lukas to be succeeded by Murray McGowan (Chief

Q1 2025 Results “Solid financial delivery, driven solely by the international cigarette division. Problems persist elsewhere ” Revenue: ₩1.49 trillion (+15.4% year-on-year) => record-high quarterly

Pharmaceutical business (including a 55% stake in Torii Pharmaceutical): Sold to Shionogi on May 7, 2025. For further details: Beyond Nicotine: Japan Tobacco Top-line &

May 2025: Imperial Brands initiates the second buyback tranche of up to £625 million Following the completion of the first £625 million tranche of the current share repurchase

Top-line & Bottom-line Results Q1 2025 Revenue: $4.52Bn (exp. $4.62Bn; down -4.2% vs. $4.72Bn in Q1 2024) Q1 2025 EPS: $1.23 (exp. $1.19; up +6%

Ahead of the Q1 2025 Earnings release Release date: April 23, 2025 (before the opening bell) Revenue: $9.14 billion expected (+4% vs. $8.79 billion in

Date: April 3, 2025 Haypp Group established new Financial Targets for 2028: – 18%-25% annual revenue growth (lower in 2025 due to the ZYN supply

Markets Day: 2030 Strategy to Drive Shareholder Returns Two core objectives: 1- Drive sustainable value in combustibles: Continue focus on top-5 markets (USA, Germany, UK,

Based in Copenhagen, Denmark, Scandinavian Tobacco Group (STG) is a leading manufacturer of cigars and smoking tobacco. The Company is the market leader in handmade

Based in Copenhagen, Denmark, Scandinavian Tobacco Group (STG) is a leading manufacturer of cigars and smoking tobacco. The Company is the market leader in handmade

The Haypp Group spearheads the global transformation from smoking to smoke-free alternatives. With origins in Scandinavia, Haypp Group is at the intersection of two mega

Background Scandinavian Tobacco Group (STG) is the world’s 11th largest publicly traded tobacco company by revenue. STG became a pure-play cigar & pipe tobacco manufacturer, following

The Haypp Group spearheads the global transformation from smoking to smoke-free alternatives. With origins in Scandinavia, Haypp Group is at the intersection of two mega

Reynolds Reinvented: 150 Years of Tobacco, Transformation, and Corporate Reinvention R.J. Reynolds Tobacco Company’s story is at once quintessentially American and quietly emblematic of the

Tobacco Segment: 88% weight in revenue, 100+% weight in adj. operating profit in FY24 Top-line & Bottom-line Results – Tobacco Segment Only Excluding Pharmaceuticals and

– Adjustment factor (LFL): ZYN sales and sales to closed states (e.g. California) in the US1 – Net sales: up +23% SEK915.2 million in Q4

Release date: February 13, 2025; before the LSE opening Consensus ahead of the release: +0.9% revenue and +1.3% operating profit growth in FY24; acceleration in

Q4 2024 & FY24 Results Revenue: ₩1.56Tn in Q4 (+8.0% year-on-year), ₩5.91Tn in FY24 (+0.8%) EBITDA: ₩272.8Bn in Q4 (+5.0%), ₩1.435Tn in FY24 (+1.9%) EBITDA

Key Business Metrics: Q3 2025 Gross Revenue is up +8% and EBITDA is up +3% (ex-paper +4.5%) despite a subdued demand environment and sharp escalation

Release date: February 6, 2025 (NYSE, before the bell) Key Business Metrics: Q4 2024 Revenue: up +7.3% to $9.71 billion (vs. $9.44 billion expected, $9.05

Top-line & Bottom-line Results Q4 2024 Revenue: $5.11Bn (exp. $5.04Bn; +1.6% vs. $5.02 in Q4 2023) Q4 2024 EPS: $1.29 (exp. $1.28; +9.3 vs. $1.18

Karelia Tobacco Company is Greece’s largest cigarette manufacturer & exporter and one of the largest independent tobacco companies in the world (i.e. not belonging to

Date/time: December 11, 2024 (Wednesday) at 8:00am UK time – BAT reaffirms its low-single digit revenue and operating profit growth guidance for 2024. The H2

November 2024: Scandinavian Tobacco completed the kr.850 million share buy-back program As of November 22, 2025, Scandinavian Tobacco Group (STG) purchased a total of 7,883,876

Expectations ahead of the release: Sell-side expects +2.9% tobacco & NGP revenue and +4.3% adjusted profit growth in FY24. Latest guidance: At the FY24 Pre-close

November 2024: Q3 2024 Results1 – Net sales: up +23% SEK9442.2 million, +25% on constant FX (drivers: +23% nicotine pouches, +2% vapes and no contribution

Top-line & Bottom-line Results Q3 2024 Revenue: $5.33Bn (exp. $5.33Bn; up +1.3% from $5.28Bn in Q3 2023) Q3 2024 EPS: $1.38 (exp. $1.35; up +7.8%

Tobacco Segment: 89% weight in revenue, 100+% weight in adjusted operating profit Top-line & Bottom-line Results – Tobacco Segment Only Excluding Pharmaceuticals and Processed Food

Key Business Metrics: Q2 2025 Gross Revenue is up +16%, driven mainly by Hotels (+12%) and Agriculture (+47%; specifically, the value-added agricultural products and leaf

Release date: Philip Morris International (PMI) issues its 2024 third-quarter and first nine-months results on Tuesday, October 22, 2024, at 9:00 a.m. ET (13:00 pm

Ahead of the event, BAT re-confirmed its FY24 and medium-term financial targets: “on track to deliver low-single digit organic revenue and adjusted operating profit growth

Expectations – Ahead of the release: Sell-side expects +2.7% tobacco & NGP revenue and +4.3% adjusted profit growth. Imperial’s latest FY24 guidance is low single-digit

Background Scandinavian Tobacco Group (STG) is the world’s 11th largest publicly traded tobacco company by revenue. STG became a pure-play cigar & pipe tobacco manufacturer, following

Q2 2024 Results Revenue: ₩1.42Tn (+6.6% year-on-year) EBITDA: ₩383.1Bn (+25.4%); EBITDA Margin: 26.9% (+4.0pp) Operating Profit: ₩321.5Bn (+30.6%) Net Income: ₩318.0Bn (+57.5%); EPS: ₩2,754 (+59.5%)

Tobacco Segment: 89% weight in revenue, 100+% weight in adj. operating profit in H1 2024 Top-line & Bottom-line Results – Tobacco Segment Only Excluding Pharmaceuticals

Key Business Metrics: Q1 2025 Gross Revenue is up +7.3%, driven mainly by Hotels, value-added agricultural products and leaf tobacco. FMCG segment, both Cigarettes (+6.1%)

Top-line & Bottom-line Results Q2 2024 Revenue: $5.28Bn (exp. $5.39Bn; down -3% from $5.44Bn in Q2 2023) Q2 2024 EPS: $1.31 (exp. $1.34; flat vs.

July 2024 BAT enters into an agreement with Goldman Sachs to purchase ordinary BAT shares from July 25, 2024 to October 14, 2024. Thereby, Goldman

Top-line – Revenue: £12.34Bn (vs. £12.47Bn expected, down -0.8% on an organic basis) – Revenue from New Categories: £1.65Bn (vs. £1.69Bn expected, up +7.4%) –

Key Business Metrics Adjusted net revenue: up +5.6% to $9.47Bn (vs. $9.18Bn expected; $8.97Bn in Q2 2023) Adjusted diluted EPS: down -0.6% to $1.59 (vs.

Philip Morris International (PMI): Headquartered in Stamford, Connecticut, USA and listed on the New York Stock Exchange (NYSE: PM). PMI is the largest publicly traded tobacco

Ahead of the H1 2024 results (to be released on July 25, 2024), BAT provided an interim business update on June 4, 2024 (Tuesday). The

Ahead of the H1 2024 results (to be released on July 25, 2024), BAT will provide an interim business update on June 4, 2024 (Tuesday).

Key Business Metrics: Q4 2024 Gross Revenue is up +2% driven by resilient performance in Cigarettes (+7.7%) and FMCG Others (+7.2%). Gross Revenue (ex-Agri Business)

Top-line & Bottom-line results Adjusted: at constant currencies – Volume: -6.3% (to 89.9Bn sticks), reflecting the wider industry decline in the markets where Imperial Brands

Q1 2024 Results “Delivers gloomy results, promises earnings turnaround in the second half” Revenue: ₩1.29Tn (-7.4% year-on-year) => decline driven by the weakness in Health-Functional

This is a sponsored post. Could China threaten the stronghold of Sweden in nicotine pouch manufacturing? Nicotine pouch is undoubtedly the fastest growing nicotine product

Tobacco Segment: 88% weight in revenue, 100+% weight in adj. operating profit in Q1 2024 Top-line & Bottom-line Results – Tobacco Segment Only Excluding Pharmaceuticals

Top-line & Bottom-line Results Q1 2024 Revenue: $4.72Bn (exp. $4.72Bn; down -1% vs. Q1 2023) Q1 2024 EPS: $1.15 (exp. $1.15; down -2.5% vs. Q1

Key Business Metrics Adjusted net revenue: up +8.6% to $8.79Bn (vs. $8.47Bn expected; +11% ex-FX) Adjusted diluted EPS: up +8.7% to $1.50 (vs. $1.41 expected;

Release date: April 25, 2024 (before the opening bell) Sell-side analyst expectations Revenue and EPS decline are already factored in. Revenue: $4.72Bn (down -0.9% vs. Q1 2023)

Release date: April 23, 2024 (before the opening bell) Sell-side analyst expectations Revenue: $8.47Bn (+4.6% vs. $8.1Bn adjusted net revenue in Q1 2023; +5.6% vs. reported) EPS:

Since we noted that “in the League of Laggards to the transformation to RRPs (Altria, Imperial, JT), we clearly favor JT due its size/scale, higher

Imperial Brands confirms that is is on track to meet H1 and FY24 guidance: – strong tobacco pricing (more than offsetting industry volume pressures in

Imperial Brands will release a pre-close trading update for the first half of FY24 (October 2023 – March 2024) on April 9, 2024. Imperial’s FY23

March 2024 Altria reduced its stake in Anheuser-Busch InBev (ABI) to buyback own shares. Altria agreed to sell 35Mn shares of ABI through a global

Presumably, everyone is aware of the “Bear Case” for Altria by now. We have written about it so many times over the past three years:

CAGNY Conference: February 2024 In an attempt to re-assure the market of its ability to deliver growth in reported basis (before endless FX adjustments), PMI

Tobacco Segment: 87% weight in revenue, 97% weight in adj. operating profit in FY23 Top-line & Bottom-line Results – Tobacco Segment Only Excluding Pharmaceuticals and

Key Business Metrics: Q4 2023 Revenue: up +8.3% to $9Bn (vs. $9Bn expected) Adjusted diluted EPS: up +12.2% to $1.36 (vs. $1.45 expected) Total volume:

Top-line – Revenue: £27.28Bn (vs. £27.9Bn expected) – Reported Revenue: down -1.3%, largely due to the sale of Russian business as well as the impact

Q4 2023 & FY23 Results Revenue: ₩1.45Tn in Q4 (+3.2% year-on-year), ₩5.87Tn in FY23 (+0.4%) EBITDA: ₩260.3Bn in Q4 (-0.6%), ₩1.41Tn in FY23 (-5.6%) EBITDA

Top-line & Bottom-line Results Q4 2023 Revenue: $5.02Bn (exp. $5.07Bn; -1.2% vs. Q4 2022) Q4 2023 EPS: $1.18 (exp. $1.17; unchanged vs. Q4 2022) FY23

Release date: February 8, 2023 (before the opening bell) BAT already released an Interim Business Update (IBU) on December 6, 2023. Recall: Our “BAT: Interim Business Update”

Release date: February 8, 2023 (before the opening bell) Sell-side analyst expectations Revenue: $9.0Bn, EPS: $1.45 Latest FY23 Guidance PMI last updated its FY23 guidance at the

Key Business Metrics Gross Revenue is up +2.1%. Gross Revenue (ex-Agri Business) is up +3.9%. Profit (before exceptional items & tax) is up +0.8%. Profit

Release date: February 1, 2024 (before the opening bell) Sell-side analyst expectations Marginal revenue and EPS decline are already factored in. Revenue: $5.07Bn (down -0.3% vs. Q4

Transformation of the Business Portfolio ITC continues the pursuit of diversifying its business and reducing its reliance on tobacco: revenue and profit from non-tobacco businesses

Highlights – Reaffirms FY23 EPS guidance: organic revenue growth in the low end of 3-5%; mid-single digit EPS growth – Continued strong volume and revenue

Ahead of the FY23 results (to be released on February 8, 2024), BAT will provide an interim business update on December 6, 2023 (Wednesday). At

November 2023 At the 2023 Investor Day, KT&G announced the plan to buy back ₩1Tn worth of stocks and cancel 15% of its outstanding shares

Top-line & Bottom-line results Adjusted: at constant currencies, excluding Russia – Volume: -7.1% (-10.4%, including the Russia exit; weakness in US mass market cigars and

Q3 2023 Results1 Despite reporting its highest-ever quarterly revenue (₩1.69Tn; +4% year-on-year) in Q3 2023, KT&G’s operating profit increased only marginally (+0.4% to ₩406.7Bn) due

Top-line & Bottom-line Results Adjusted, at constant currencies; Tobacco only – excluding Pharmaceuticals & Processed Food Revenue: +4.7% driven by positive price/mix variance and volume

Top-line & Bottom-line Results Revenue: $5.28Bn (exp. $5.43Bn; down -2.5% vs. Q3 2022) EPS: $1.28 (exp. $1.29; unchanged vs. Q3 2022) Narrows the FY23 guidance:

Release date: October 26, 2023 (before the opening bell) Sell-side analyst expectations Revenue: $5.43Bn (up +0.3% vs. Q3 2022) EPS: $1.29 (up +1% vs. Q3 2022) FY23

Key Business Metrics Revenue: up +9.3% to $9.14Bn (vs. $9.2Bn expected). Surpassed the $9Bn threshold for the first-time Adjusted diluted EPS: up +20.3% to $1.67

Key Business Metrics Gross revenue is up +3.4%. Gross revenue (excluding wheat & rice exports) is up +8.9%. Wheat & Rice exports: Geopolitical tensions &

Release date: October 19, 2023 (before the opening bell) Sell-side analyst expectations Revenue: $9.2Bn EPS: $1.61 (up +16% on adjusted, ex-currency basis) PMI last updated its Q3

ITC is the tobacco market leader in India, world’s most populous country, and is the fourth largest publicly-traded tobacco company in the world by market

October 2023: New patents granted Lexaria is granted two new patents in Canada, associated to: – delivering lipophilic (fat-based) active drugs and active molecules suspended

(October 5, 2023) Imperial Brands confirms that it is on track to deliver FY23 guidance and announces further £1.1Bn share buyback (~8% of share capital).

Imperial Brands will provide a pre-close trading update for the FY23 (October 2022 – September 2023) on October 5, 2023. In the first half of

September 2023 At the 2023 Investor Day, PMI announced that no share repurchases are foreseen in the 2024-26 period as it prioritizes debt reduction. By

PMI will host an Investor Day on Sept 28, 2023 – the first one since Feb 2021. This is an opportunity for the PMI Management

Philip Morris International (PMI) appointed Victoria Harker, an experienced US public-company CFO, to its Board of Directors (effective January 1, 2024). This appointment is important & meaningful. In

Sell-side analysts believe that Philip Morris International (PMI)’s healthy business fundamentals and encouraging growth outlook aren’t yet reflected in the share price. The average analyst

Another dividend hike Altria increased its quarterly Dividend by 4.3% to $0.98/share on August 24, 2023. The new annualized dividend rate is $3.92 per share,

Top-line & Bottom-line Results Revenue: $5.44Bn (exp. $5.43Bn; up +1.2% vs. Q2 2022) EPS: $1.31 (exp. $1.30; up 4% vs. Q2 2022) Reaffirms the FY23

Release date: August 1, 2023 (Tuesday) – 9:00am ET Sell-side consensus Revenue: $5.43Bn (+1% vs. $5.37Bn in Q2 2022) EPS: $1.30 (+3% vs. $1.26 in

Top-line – Revenue: £13.44Bn (vs. £13.3Bn expected) – Revenue up +2.8% (New Categories up +27.9%) – Revenue from New Categories: 12.3% of total Bottom-line –

Key Business Metrics Revenue: up +10.5% to $8.97Bn (expected $8.7Bn) Adjusted diluted EPS: up +16.9% to $1.60 (expected $1.48) Total volume: up +3.3% to 188.4Bn

Guidance & Expectations EPS (adjusted diluted): $1.42-$1.47, including an unfavorable FX impact of $0.13/share (revised as “towards the top-end” at the DB conference) Heated Tobacco

Key Highlights – On track to meet FY23 guidance – Disappointing US combustibles performance: but, the volume share has grown sequentially since the start of

Top-line & Bottom-line results Adjusted: at constant currencies, excluding Russia – Volume: -6.8% (including the Russia exit, -12.7%) – Robust combustible pricing: +9.3% (partially offset

May 2023: New CEO The Board announces that – the current CEO is stepping down from the Board of Directors with immediate effect – the

Top-line & Bottom-line results Adjusted, at constant currencies; Tobacco only – excluding Pharmaceuticals & Processed Food Revenue +6.3% (positive pricing contributions) Operating profit +4.6% (lower

Top-line & Bottom-line results Revenue: down -1.2% to $4.76Bn in Q1 2023 (expected $4.9Bn) Adjusted diluted EPS: up +5.4% to $1.18 in Q1 2023 (expected

Bottom-line results & Volume progression Revenue: up +3.2% to $8.02Bn in Q1 2023 (expected $8.11Bn) Adjusted diluted EPS: down -4.4% to $1.38 in Q1 2023

Guidance On track to meet full-year guidance H1 2023 Revenue (excl. the impact of Russia exit) & Operating Profit: at a similar level to H1

2023-2028: 5-year Guidance – Mid-single digit annual EPS growth (in line with the 5% EPS growth posted in 2022, but significantly lower than the 8.8%

NJOY acquisition – confirmed Altria acquires NJOY for ~$2.75Bn in cash. The Transaction terms also include additional $500Mn in cash payments that are contingent on

Great progress in transitioning Montego brand strategy from volume-based to income-based, resulting in profitability turnaround (recall: Montego is Vector’s largest brand since Q2 2022 and

Top-line & Bottom-line results Adjusted, at constant currencies; Tobacco only – excluding Pharmaceuticals & Processed Food Core revenue: up +4.8% (RRP revenue: up +4.4%) Operating

In FY22, KT&G posts record earnings, largely on upbeat sales of heat-not-burn tobacco products in Korea & overseas. Total cigarette and HnB volume reaches 101.5Bn

Bottom-line results & Volume progression EPS: up +20.8% to $1.23 in Q4; up +11.9% to $5.34 in FY22 Total volume: +2.6% in Q4; 3.2% in

Top-line & Bottom-line results Adjusted, at constant currencies Net revenue up +2.3% (New Category net revenue up +37%) Operating profit up +4.3%; operating margin +90

Top-line & Bottom-line results Revenue: down -0.1% to $5.08Bn in Q4 (expected $5.15Bn); down -2% to $20.7Bn in FY22 Adjusted diluted EPS: up +8.3% to

Top-line & Bottom-line results Adjusted, at constant currencies Net revenue up +1.5% (NGP net revenue up +10.8%) Operating profit up +1.8% EPS up +4.9% Key